The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland—The Results of a National Online Survey
Authors:
- Dariusz WalkowiakDWDariusz Walkowiak
- Bożena MikołućBMBożena Mikołuć
- Renata MozrzymasRMRenata Mozrzymas
- Łukasz KałużnyŁKŁukasz Kałużny
- Bożena DidyczBDBożena Didycz
- Dorota Korycińska-ChaabanDKDorota Korycińska-Chaaban
- Michał PatalanMPMichał Patalan
- Joanna JagłowskaJJJoanna Jagłowska
- Agnieszka ChrobotACAgnieszka Chrobot
- Ewa StarosteckaESEwa Starostecka
- Joanna ZarębskaJZJoanna Zarębska
- Jarosław WalkowiakJWJarosław Walkowiak
Open Access
- 13 June 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (12) , 6399
Abstract
There is agreement that the pandemic has affected the healthcare system and behaviour of patients. This study aims to identify problems encountered by patients with phenylketonuria (PKU) and their parents/caregivers during the six-week pandemic lockdown in Poland (15 March to 30 April 2020). To determine the factors that influenced health and treatment-related issues, as well as the respondents’ perception of the impact of the pandemic, study participants were asked to complete a non-validated online questionnaire comprising 31 questions (including 27 single-choice, two multiple-choice and two open-ended ones). A total of 571 patients or their parents completed the questionnaire, with 9.5% of respondents not performing any blood phenylalanine (Phe) test in the analysed period, 21.3% declaring a blood Phe increase, and 15.3% a decrease. Increased problems in contacting the doctor or dietitian were reported by 26.1% of subjects, whereas 39.3% of them felt restricted access to dietary products. Most (63.4%) participants were satisfied with remote contact with their PKU clinic. Better compliance was associated with higher odds of acceptance of remote contact and of reporting fewer problems with contacting the doctor, and with lower odds of missing Phe testing. Self-reported high stress was associated with higher odds of reporting the limited availability of low-Phe products and Phe-free formulas, as well as with increased Phe concentrations and non-PKU-related health problems. These patients also had poor dietary compliance and experienced more problems in contacting specialists. Health and treatment-related problems experienced during the pandemic lockdown were related to a higher intensity of stress in patient’s family and worse therapy compliance before the pandemic. Previous experience of remote visits resulted in a better perception of this method of contact. It seems that this form of communication should be popularized and improved to increase therapy effectiveness in case of different limitations in the future. Special attention should be paid to vulnerable patients who may be at extra risk when the provision of standard care is affected.Keywords
This publication has 39 references indexed in Scilit:
- Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New TreatmentsFrontiers in Psychiatry, 2019
- Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims dataOrphanet Journal of Rare Diseases, 2019
- Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuriaMolecular Genetics and Metabolism, 2018
- Neuropsychiatric comorbidities in adults with phenylketonuria: A retrospective cohort studyMolecular Genetics and Metabolism, 2017
- Social‐cognitive functioning and social skills in patients with early treated phenylketonuria: a PKU‐COBESO studyJournal of Inherited Metabolic Disease, 2016
- Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countriesOrphanet Journal of Rare Diseases, 2015
- Adherence to diet and quality of life in patients with phenylketonuriaActa Paediatrica, 2011
- Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidenceMolecular Genetics and Metabolism, 2010
- Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normalThe Journal of Pediatrics, 2002
- Psychiatric Disorders in Adult Patients With Early-treated PhenylketonuriaPediatrics, 1997